Bosh sahifa2196 • HKG
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Yopilish kursi
13,76 $
Kunlik diapazon
13,84 $ - 14,04 $
Yillik diapazon
11,52 $ - 19,50 $
Bozor kapitalizatsiyasi
61,42 mlrd HKD
Oʻrtacha hajm
5,41 mln
Narx/foyda
12,65
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CNY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 9,42 mlrd | -7,26% |
Joriy xarajat | 3,85 mlrd | -6,02% |
Sof foyda | 764,76 mln | 25,42% |
Sof foyda marjasi | 8,12 | 35,33% |
Har bir ulushga tushum | — | — |
EBITDA | 1,28 mlrd | -22,50% |
Amaldagi soliq stavkasi | 30,13% | — |
Balans
Jami aktivlari
Jami passivlari
| (CNY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 16,07 mlrd | 6,98% |
Jami aktivlari | 117,99 mlrd | 3,73% |
Jami passivlari | 57,14 mlrd | 1,66% |
Umumiy kapital | 60,85 mlrd | — |
Tarqatilgan aksiyalar | 2,64 mlrd | — |
Narxi/balansdagi bahosi | 0,76 | — |
Aktivlardan daromad | 1,37% | — |
Kapitaldan daromad | 1,68% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CNY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 764,76 mln | 25,42% |
Operatsiyalardan naqd pul | 1,06 mlrd | 15,08% |
Sarmoyadan naqd pul | -185,09 mln | 84,46% |
Moliyadan naqd pul | -633,63 mln | -742,38% |
Naqd pulning sof oʻzgarishi | 245,87 mln | 262,03% |
Boʻsh pul | -1,89 mlrd | -2,13% |
Haqida
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Tashkil etilgan
1994
Sayt
Xodimlar soni
40 557
